V89-26206-84448
2 vaccinations
1 coded response
4 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 302 / GA
- Registered
- 2021-06-25
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-24
Dose 1 — Pfizer-BioNTech
-
2021-06-25
Registered in v-safe
-
2021-06-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-06-26
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-07-15
Dose 2 — Pfizer-BioNTech
-
2021-07-15
Survey response — day 0, dose 2MedDRA: Nasal congestion — Feeling: Fair · Site: PainFree text: Stuffy noseMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-17
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Itching · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-24 | Pfizer-BioNTech | No |
| 2 | 2021-07-15 | Pfizer-BioNTech | No |
Free text
Release 9 — day 0, dose 2
Systemic reaction (other): Stuffy nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Nasal congestion | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release